Insider Stock Trading History of Haviland Kate


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Haviland Kate since year 2005. The trader's CIK number is 1663022. At the time of this reporting, Haviland Kate is the Chief Business Officer of Blueprint Medicines Corp . (stock ticker symbol BPMC). See this page for all insider trading activities at Blueprint Medicines Corp .


Stock purchases, sales, and option exercises reported by insider Haviland Kate since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-03-16 BPMC Blueprint Medicines Corp Option Ex 4,071 26.16 106,517
2018-03-16 BPMC Blueprint Medicines Corp Sale 4,071 100.68 409,876
2018-03-01 BPMC Blueprint Medicines Corp Option Ex 2,800 36.05 100,939
2018-03-01 BPMC Blueprint Medicines Corp Sale 2,800 90.00 252,000
2018-02-27 BPMC Blueprint Medicines Corp Option Ex 3,200 36.05 115,359
2018-02-27 BPMC Blueprint Medicines Corp Sale 3,200 89.05 284,953
2018-02-12 BPMC Blueprint Medicines Corp Option Ex 6,775 16.28 110,297
2018-02-12 BPMC Blueprint Medicines Corp Sale 6,775 74.69 506,024
2017-11-21 BPMC Blueprint Medicines Corp Option Ex 5,874 16.28 95,628
2017-10-05 BPMC Blueprint Medicines Corp Option Ex 5,449 16.28 88,709
2017-10-05 BPMC Blueprint Medicines Corp Sale 5,449 66.45 362,102
2017-09-18 BPMC Blueprint Medicines Corp Option Ex 6,356 16.28 103,475
2017-09-18 BPMC Blueprint Medicines Corp Sale 6,356 60.03 381,550
2017-07-05 BPMC Blueprint Medicines Corp Sale 7,265 53.65 389,781
2017-07-05 BPMC Blueprint Medicines Corp Option Ex 7,265 16.28 118,274
2017-06-28 BPMC Blueprint Medicines Corp Option Ex 6,357 16.28 103,491
2017-06-28 BPMC Blueprint Medicines Corp Sale 6,357 50.00 317,850
2017-03-14 BPMC Blueprint Medicines Corp Option Ex 12,714 16.28 206,983
2017-03-14 BPMC Blueprint Medicines Corp Sale 12,714 40.01 508,687

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Haviland Kate (Chief Business Officer of Blueprint Medicines Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.